Nature Cell Co., Ltd., a leading biotech company based in Korea, announced on November 19th that it has confirmed the success of a new treatment involving the intravenous and spinal cavity administration of autologous adipose stem cells. This treatment was developed in collaboration with Japan Angel Stem Cell (JASC) and R Bio, which utilized stem cell culture media produced and supplied by Nature Cell. The new treatment has shown promising outcomes in the treatment of Parkinson’s disease.
Menu
